Lumefantrine
From Wikipedia, the free encyclopedia
|
Lumefantrine
|
|
| Systematic (IUPAC) name | |
| 2-(dibutylamino)-1-[(9E)-2,7-dichloro- 9-[(4-chlorophenyl)methylidene] fluoren-4-yl]ethanol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C30H32Cl3NO |
| Mol. mass | 528.939 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Lumefantrine (or benflumetol) is an antimalarial drug.
The term "co-artemether" is sometimes used to describe the administration of lumefantrine with artemether.[1]
[edit] References
- ^ Toovey S, Jamieson A, Nettleton G (2003). "Successful co-artemether (artemether-lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique". Travel medicine and infectious disease 1 (3): 177–9. doi:. PMID 17291911.
|
||||||||||||||||||||

